The International Myeloma Foundation Applauds Expansion Of VELCADE(R) For Previously Untreated Patients In Europe And Canada

The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - today heralded the expansion of treatment options for previously untreated patients with multiple myeloma, giving patients in Canada and Europe access to drugs similar to what is available to patients in the United States.